Review
Adverse effects of bisphosphonates
Efectos adversos de los bisfosfonatos
Luis Arboleya
, Mercedes Alperi, Sara Alonso
Servicio de Reumatología, Hospital Universitario Central de Asturias, Oviedo, Spain
Read
8103
Timeswas read the article
3562
Total PDF
4541
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 1 | 0 | 1 |
| 2025 5 | 128 | 76 | 204 |
| 2025 4 | 76 | 64 | 140 |
| 2025 3 | 62 | 59 | 121 |
| 2025 2 | 86 | 61 | 147 |
| 2025 1 | 33 | 55 | 88 |
| 2024 12 | 33 | 54 | 87 |
| 2024 11 | 48 | 87 | 135 |
| 2024 10 | 30 | 59 | 89 |
| 2024 9 | 37 | 47 | 84 |
| 2024 8 | 48 | 59 | 107 |
| 2024 7 | 35 | 47 | 82 |
| 2024 6 | 53 | 65 | 118 |
| 2024 5 | 39 | 56 | 95 |
| 2024 4 | 37 | 40 | 77 |
| 2024 3 | 28 | 41 | 69 |
| 2024 2 | 29 | 35 | 64 |
| 2024 1 | 23 | 30 | 53 |
| 2023 12 | 14 | 32 | 46 |
| 2023 11 | 26 | 34 | 60 |
| 2023 10 | 28 | 45 | 73 |
| 2023 9 | 24 | 50 | 74 |
| 2023 8 | 24 | 21 | 45 |
| 2023 7 | 11 | 23 | 34 |
| 2023 6 | 53 | 34 | 87 |
| 2023 5 | 29 | 24 | 53 |
| 2023 4 | 17 | 25 | 42 |
| 2023 3 | 33 | 40 | 73 |
| 2023 2 | 18 | 31 | 49 |
| 2023 1 | 22 | 30 | 52 |
| 2022 12 | 37 | 41 | 78 |
| 2022 11 | 42 | 31 | 73 |
| 2022 10 | 29 | 20 | 49 |
| 2022 9 | 34 | 47 | 81 |
| 2022 8 | 28 | 48 | 76 |
| 2022 7 | 22 | 61 | 83 |
| 2022 6 | 35 | 48 | 83 |
| 2022 5 | 40 | 57 | 97 |
| 2022 4 | 66 | 66 | 132 |
| 2022 3 | 41 | 49 | 90 |
| 2022 2 | 28 | 44 | 72 |
| 2022 1 | 23 | 28 | 51 |
| 2021 12 | 22 | 56 | 78 |
| 2021 11 | 35 | 70 | 105 |
| 2021 10 | 85 | 74 | 159 |
| 2021 9 | 64 | 54 | 118 |
| 2021 8 | 60 | 50 | 110 |
| 2021 7 | 21 | 34 | 55 |
| 2021 6 | 28 | 52 | 80 |
| 2021 5 | 38 | 41 | 79 |
| 2021 4 | 154 | 113 | 267 |
| 2021 3 | 93 | 34 | 127 |
| 2021 2 | 55 | 29 | 84 |
| 2021 1 | 34 | 20 | 54 |
| 2020 12 | 35 | 31 | 66 |
| 2020 11 | 33 | 25 | 58 |
| 2020 10 | 17 | 16 | 33 |
| 2020 9 | 19 | 21 | 40 |
| 2020 8 | 17 | 25 | 42 |
| 2020 7 | 19 | 16 | 35 |
| 2020 6 | 32 | 24 | 56 |
| 2020 5 | 23 | 19 | 42 |
| 2020 4 | 24 | 18 | 42 |
| 2020 3 | 17 | 11 | 28 |
| 2020 1 | 4 | 0 | 4 |
| 2019 9 | 4 | 0 | 4 |
| 2019 6 | 2 | 0 | 2 |
| 2019 3 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 7 | 1 | 8 |
| 2018 4 | 29 | 15 | 44 |
| 2018 3 | 27 | 21 | 48 |
| 2018 2 | 17 | 10 | 27 |
| 2018 1 | 11 | 8 | 19 |
| 2017 12 | 20 | 10 | 30 |
| 2017 11 | 20 | 8 | 28 |
| 2017 10 | 29 | 5 | 34 |
| 2017 9 | 14 | 10 | 24 |
| 2017 8 | 19 | 8 | 27 |
| 2017 7 | 18 | 15 | 33 |
| 2017 6 | 33 | 26 | 59 |
| 2017 5 | 38 | 11 | 49 |
| 2017 4 | 26 | 9 | 35 |
| 2017 3 | 23 | 29 | 52 |
| 2017 2 | 18 | 4 | 22 |
| 2017 1 | 15 | 5 | 20 |
| 2016 12 | 53 | 16 | 69 |
| 2016 11 | 47 | 6 | 53 |
| 2016 10 | 70 | 12 | 82 |
| 2016 9 | 49 | 1 | 50 |
| 2016 8 | 23 | 1 | 24 |
| 2016 7 | 12 | 4 | 16 |
| 2016 6 | 0 | 3 | 3 |
| 2016 5 | 0 | 3 | 3 |
| 2016 3 | 4 | 3 | 7 |
| 2016 2 | 6 | 0 | 6 |
| 2015 12 | 5 | 0 | 5 |
| 2015 11 | 1 | 0 | 1 |
| 2015 9 | 2 | 14 | 16 |
| 2015 8 | 3 | 0 | 3 |
| 2015 7 | 20 | 9 | 29 |
| 2015 6 | 38 | 11 | 49 |
| 2015 5 | 47 | 25 | 72 |
| 2015 4 | 35 | 16 | 51 |
| 2015 3 | 48 | 12 | 60 |
| 2015 2 | 50 | 17 | 67 |
| 2015 1 | 41 | 35 | 76 |
| 2014 12 | 27 | 22 | 49 |
| 2014 11 | 37 | 21 | 58 |
| 2014 10 | 30 | 17 | 47 |
| 2014 9 | 30 | 18 | 48 |
| 2014 8 | 31 | 26 | 57 |
| 2014 7 | 32 | 21 | 53 |
| 2014 6 | 53 | 13 | 66 |
| 2014 5 | 41 | 22 | 63 |
| 2014 4 | 43 | 14 | 57 |
| 2014 3 | 57 | 18 | 75 |
| 2014 2 | 50 | 18 | 68 |
| 2014 1 | 44 | 19 | 63 |
| 2013 12 | 38 | 9 | 47 |
| 2013 11 | 52 | 35 | 87 |
| 2013 10 | 64 | 23 | 87 |
| 2013 9 | 47 | 15 | 62 |
| 2013 8 | 47 | 18 | 65 |
| 2013 7 | 42 | 14 | 56 |
| 2013 6 | 28 | 13 | 41 |
| 2013 5 | 23 | 14 | 37 |
| 2013 4 | 39 | 16 | 55 |
| 2013 3 | 26 | 25 | 51 |
| 2013 2 | 22 | 19 | 41 |
| 2013 1 | 50 | 12 | 62 |
| 2012 12 | 60 | 16 | 76 |
| 2012 11 | 37 | 11 | 48 |
| 2012 10 | 10 | 5 | 15 |
| 2012 9 | 25 | 8 | 33 |
| 2012 7 | 1 | 0 | 1 |
| 2012 6 | 3 | 0 | 3 |
| 2012 5 | 2 | 0 | 2 |
| 2012 4 | 4 | 0 | 4 |
| 2012 2 | 2 | 0 | 2 |
| 2012 1 | 3 | 0 | 3 |
| 2011 12 | 4 | 0 | 4 |
| 2011 11 | 2 | 0 | 2 |
| 2011 10 | 4 | 0 | 4 |
| 2011 9 | 6 | 0 | 6 |
| 2011 8 | 4 | 0 | 4 |
| 2011 7 | 2 | 0 | 2 |
| 2011 6 | 11 | 0 | 11 |
| 2011 5 | 2 | 0 | 2 |
Show all
